Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isotretinoin for LSIL in HIV-Infected Women
NCT00001073Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of isotretinoin in Squamous Intraepithelial Lesion (SIL), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
isotretinoin
03
Conditions
Squamous Intraepithelial Lesion (SIL)
Beyond the preview
Go deeper on NCT00001073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001073.